Baloxavir Marboxil: The First Cap-Dependent Endonuclease Inhibitor for the Treatment of Influenza.

Published in: The Annals of pharmacotherapy (2019)

Baloxavir is a new antiviral medication for the treatment of influenza. Given the new mechanism of action, baloxavir may be useful in treating patients with resistant viruses.

Keyphrases

healthcare
emergency department
combination therapy
oxidative stress
adverse drug
electronic health record